| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +7.5 K | 0.2% | $7.81 | +$58.6 K |
| Sells | 3 | -3.74 M | 99.8% | $8.11 | -$30.4 M |
| Net | -2 | -3.74 M | -99.6% | -$30.3 M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 10%+ Owner | $60.5 M | Jan 24, 2024 | ||
| James Topper | Director, 10%+ Owner | $53.4 M | May 23, 2024 | ||
| Takeda Pharmaceutical Co Ltd | 10%+ Owner | $30.4 M | -$30 M | -49.7% | Jan 24, 2024 |
| David A. Socks | Director | $11.2 M | May 23, 2024 | ||
| Azmi Nabulsi | Chief Operating Officer | $10.8 M | May 31, 2024 | ||
| Terrie Curran | President and Chief Executive, Director | $3.78 M | -$154 K | -3.91% | Mar 22, 2024 |
| Molly Henderson | CFO and CBO | $1.16 M | -$213 K | -15.5% | May 31, 2024 |
| Asit Parikh | Director | $597 K | +$58.6 K | +10.9% | May 23, 2024 |
| Frank Karbe | Director | $452 K | May 29, 2024 | ||
| Michael F. Cola | Director | $267 K | May 23, 2024 | ||
| Mark Stenhouse | Director | $178 K | May 23, 2024 | ||
| Heidi Fields | Director | $178 K | May 23, 2024 | ||
| Anthony J. Guzzo | VP, Chief Accounting Officer | $71.8 K | Jan 19, 2022 | ||
| Tadataka Yamada | Director | May 21, 2021 |
| Insider | Class | Transaction | % | Value $ | Price $ | Shares | Shares Owned | Date | Ownership |
|---|